Issue 18, 2021

A two-pronged photodynamic nanodrug to prevent metastasis of basal-like breast cancer

Abstract

A two-pronged concept combining photodynamic therapy (PDT) and epithelial–mesenchymal transition (EMT) blockade in a minimalist nanoplatform was proposed to combat basal-like breast cancer (BLBC) metastasis. Based on PDT-mediated tumor killing and epalrestat (Epa)-mediated EMT blockade, as-prepared Ce6/Epa nanoparticles prevented BLBC metastasis effectively in vivo, providing a very promising two-pronged strategy against BLBC metastasis.

Graphical abstract: A two-pronged photodynamic nanodrug to prevent metastasis of basal-like breast cancer

Supplementary files

Article information

Article type
Communication
Submitted
16 Dec 2020
Accepted
21 Jan 2021
First published
22 Jan 2021

Chem. Commun., 2021,57, 2305-2308

A two-pronged photodynamic nanodrug to prevent metastasis of basal-like breast cancer

J. Zhang, N. Wang, Q. Li, Y. Zhou and Y. Luan, Chem. Commun., 2021, 57, 2305 DOI: 10.1039/D0CC08162K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements